Bolt Biotherapeutics Inc (BOLT) stock is lower by -85.01% since Friday, February 5, 2021 when the stock began trading, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BOLT stock a score of 30 out of a possible 100. That rank is primarily influenced by a short-term technical score of 1. BOLT's rank also includes a long-term technical score of 1. The fundamental score for BOLT is 90. In addition to the average rating from Wall Street analysts, BOLT stock has a mean target price of $38.50. This means analysts expect the stock to climb 698.76% over the next 12 months.
Is Bolt Biotherapeutics Inc (BOLT) Stock Worth a Buy Wednesday?
BOLT has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on BOLT!